MDS (MYELODYSPLASTIC SYNDROME)
Clinical trials for MDS (MYELODYSPLASTIC SYNDROME) explained in plain language.
Never miss a new study
Get alerted when new MDS (MYELODYSPLASTIC SYNDROME) trials appear
Sign up with your email to follow new studies for MDS (MYELODYSPLASTIC SYNDROME), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Which chemo works best before a transplant? new trial aims to find out.
Disease control Not yet recruitingThis study compares two chemotherapy drugs, treosulfan and melphalan, given before a stem cell transplant in people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). About 220 adults whose cancer is in remission or stable will take part. The goal is to see whic…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE2 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated May 26, 2026 05:11 UTC
-
New drug combo may boost transplant success in leukemia
Disease control Not yet recruitingThis study tests whether adding the drug venetoclax to standard chemotherapy before a stem cell transplant can improve survival for people with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS). About 27 adults aged 18–75 will receive this experimental cond…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE2 • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New registry aims to unlock secrets of rare blood cancers
Knowledge-focused Not yet recruitingThis study creates a registry of 500 adults with myelodysplastic syndromes (MDS) or related conditions. Researchers will collect medical data and blood or bone marrow samples over time to track how these diseases progress. The goal is to better understand these rare blood disorde…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Sponsor: Technische Universität Dresden • Aim: Knowledge-focused
Last updated May 26, 2026 05:15 UTC
-
CAR-T therapy for blood cancers: how do patients fare years later?
Knowledge-focused Not yet recruitingThis study follows about 49 people with relapsed acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who previously received ARD103 CAR-T cell therapy in an earlier trial. Researchers will track long-term side effects and overall survival to understand the treatment's …
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Sponsor: ARCE Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 05:11 UTC